SECURITIES AMENDMENT AGREEMENTSecurities Amendment Agreement • February 27th, 2020 • Emmaus Life Sciences, Inc. • Pharmaceutical preparations • New York
THIS SECURITIES AMENDMENT AGREEMENT (this “Agreement”), dated as February 21, 2020, is entered into by and among EMI Holding, Inc. (formerly known as “Emmaus Life Sciences, Inc.”), a Delaware corporation (the “Company”), Emmaus Life Sciences, Inc.,(formerly known as “MYnd Analytics, Inc.”), a Delaware corporation and the parent company of EMI (“Emmaus”) and the parties identified as “Holders” on the signature page hereto (the “Holders”).
